24 People, one test: Boosting test efficiency using pooled serum antibody testing for SARS-CoV-2
Andreas Zautner
medRxiv (Cold Spring Harbor Laboratory), 2020
View PDFchevron_right
Comparison of SARS-CoV-2 serological tests with different antigen targets
G. Greub
Journal of Clinical Virology, 2021
View PDFchevron_right
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection
M. Lappalainen
Journal of Clinical Virology, 2021
View PDFchevron_right
A serological assay to detect SARS-CoV-2 seroconversion in humans
Luz Amarilis Lugo
medRxiv (Cold Spring Harbor Laboratory), 2020
View PDFchevron_right
The kinetic of SARS-CoV-2 antibody (Ab) decline determines the threshold for Ab persistence up to one year
Hannes Stockinger
medRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection by targeting cooperatively host TMPRSS2 in vitro and in vivo
Magnar Bjørås
bioRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Determinants for detection of infection with SARS-CoV-2 Omicron variants of concern in health care workers by rapid antigen tests
Hedwig Roggendorf
medRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right
Stability of SARS-CoV-2 in different environmental conditions
Dr. Masoumeh Aslanimehr PhD
The Lancet Microbe, 2020
View PDFchevron_right
Estimating R0 of SARS-COV-2 in Healthcare Settings
Pascal Crépey
2020
View PDFchevron_right
Final Henok ReviewReverse vaccinology
Henok Mulatu
View PDFchevron_right
1 Temporal signal and the phylodynamic threshold of SARS-CoV-2 2 3
Leo Featherstone
2020
View PDFchevron_right
Crasquin et al 2008 RISP
Hugo F R Bucher
View PDFchevron_right
Serial SARS-CoV-2 antibody titers in vaccinated dialysis patients: prevalence of unrecognized infection and duration of seroresponse
Kenneth Abreo
medRxiv (Cold Spring Harbor Laboratory), 2023
View PDFchevron_right
Immunogenicity following two doses of BBIBP-CorV vaccine and a third booster dose with viral vector and Mrna COVID-19 vaccines against delta and omicron variants in prime immunized adults with two doses of BBIBP-CorV vaccine
Ritthideach Yorsaeng
medRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
bram Slechten
bioRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Surveillance of SARS-CoV-2 variants in Argentina: detection of Alpha, Gamma, Lambda, Epsilon and Zeta in locally transmitted and imported cases
Andrea Falaschi
2021
View PDFchevron_right
Deep Mutational Engineering of broadly-neutralizing and picomolar affinity nanobodies to accommodate SARS-CoV-1 & 2 antigenic polymorphism
Philippe Cuniasse
bioRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
First detection of SARS-CoV-2 Delta variant (B.1.617.2) in the wastewater of (Ahmedabad), India
Dalip Singh Rathore
medRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases
Vincent Maréchal
2020
View PDFchevron_right
Sharmin et al 2008
Saiful Islam
View PDFchevron_right
Combined oropharyngeal/nares and nasopharyngeal swab sampling remain effective for molecular detection of SARS-CoV-2 Omicron variant
Gregory R McCracken
Journal of Medical Microbiology, 2022
View PDFchevron_right
Vaccine hesitancy for coronavirus SARS-CoV-2 in North India
PRAJJVAL SINGH
medRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Detection of SARS-CoV-2 in Schools Using Built Environment Testing in Ottawa, Canada: A Multi-Facility Prospective Surveillance Study
tasha burhunduli
medRxiv (Cold Spring Harbor Laboratory), 2023
View PDFchevron_right
In vivo translational efficiency of different hepatitisC virus 5′-UTRs
Emanuele Buratti
FEBS Letters, 1997
View PDFchevron_right
Cirilli et al 2005
morteza yousefi
View PDFchevron_right
Intra-Host Evolution Provides for Continuous Emergence of SARS-CoV-2 Variants
angelica juarez
SSRN Electronic Journal, 2021
View PDFchevron_right
Disparities in SARS-CoV-2 Vaccination-to-Infection Risk, Massachusetts 2020-2021
Thomas Stopka
medRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Changes in Transmission and Symptoms of SARS-CoV-2 in United States Households, April 2020–September 2022
Clea Sarnquist
medRxiv (Cold Spring Harbor Laboratory), 2023
View PDFchevron_right
Evaluation of Integrated SARS-CoV-2 Genome Presence in PBMC, Oropharyngeal, and Nasopharyngeal Samples of COVID-19 Patients
Farah Bokharaei-Salim
Jundishapur journal of microbiology, 2024
View PDFchevron_right
Abstracts of Presentations at the 2005 Spring Meeting of the Korean Society of Mycology at The University of Seoul, Seoul, Korea, May 13
Jong Kyu Lee
Mycobiology, 2005
View PDFchevron_right
Detection Of SARS-COV-2 Variants Of Concern In Wastewater Of Leuven, Belgium
Annabel Rector
medRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right
56 Acosta Hospitaleche and Di Carlo, 2012 scapula
Carolina Acosta Hospitaleche
View PDFchevron_right
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study
Karolin Toompere
medRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Sobre Biotecnología y OGM's (2013)
Pedro Nájera
View PDFchevron_right
A rapid and simple protocol for concentration of SARS-CoV-2 from sewage
Damian Costamagna
Journal of Virological Methods, 2021
View PDFchevron_right